Japan Tissue Engineering Co (TSE:7774) Additional Paid-In Capital : 円2,789 Mil(As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co Additional Paid-In Capital?

Japan Tissue Engineering Co's quarterly additional paid-in capital stayed the same from Mar. 2024 (円2,789 Mil) to Sep. 2024 (円2,789 Mil) and stayed the same from Sep. 2024 (円2,789 Mil) to Mar. 2025 (円2,789 Mil).

Japan Tissue Engineering Co's annual additional paid-in capital stayed the same from Mar. 2023 (円2,789 Mil) to Mar. 2024 (円2,789 Mil) and stayed the same from Mar. 2024 (円2,789 Mil) to Mar. 2025 (円2,789 Mil).

Japan Tissue Engineering Co Additional Paid-In Capital Historical Data

The historical data trend for Japan Tissue Engineering Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Japan Tissue Engineering Co Additional Paid-In Capital Chart

Japan Tissue Engineering Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Additional Paid-In Capital

Get a 7-Day Free Trial

2,788.76

Japan Tissue Engineering Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial															2,788.76	2,788.76	2,788.76	2,788.76	2,788.76

Japan Tissue Engineering Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Japan Tissue Engineering Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Japan Tissue Engineering Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Japan Tissue Engineering Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022

Website

https://www.jpte.co.jp

Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Japan Tissue Engineering Co Headlines

No Headlines